Sabra Health Care REIT, Inc.
For the period ended Dec 31, 2025. Filed Feb 12, 2026.
View on SEC.govAbout this filing
A company's yearly report to the SEC, with audited financial statements. It is the fullest account a company gives of its business, its finances and the risks it sees.
FY2025 · Filed Feb 12, 2026
SBRA$21.47+2.1%Stored close · as of Nov 9, 2026
Extracted filing text, with the paragraph anchors used by the comparison.
See the whole filing, with its images and exhibitsContents
Consolidated Statements of Equity
| Common Stock · Additional Paid-in Capital · Cumulative Distributions in Excess of Net Income · Accumulated Other Comprehensive Income (Loss) · Total Stockholders’Equity · Noncontrolling Interests · Total Equity | ||||||||
|---|---|---|---|---|---|---|---|---|
| Shares · Amounts | ||||||||
| Balance, December 31, 2022 | 231,009,295 | $2,310 | $4,486,967 | $(1,451,945) | $19,063 | $3,056,395 | $— | $3,056,395 |
| Net income | — | — | — | 13,756 | — | 13,756 | — | 13,756 |
| Other comprehensive income | — | — | — | — | 4,682 | 4,682 | — | 4,682 |
| Amortization of stock-based compensation | — | — | 10,559 | — | — | 10,559 | — | 10,559 |
| Common stock issuance, net | 256,725 | 3 | (2,771) | — | — | (2,768) | — | (2,768) |
| Common dividends ($1.20 per share) | — | — | — | (280,090) | — | (280,090) | — | (280,090) |
| Balance, December 31, 2023 | 231,266,020 | 2,313 | 4,494,755 | (1,718,279) | 23,745 | 2,802,534 | — | 2,802,534 |
| Net income | — | — | — | 126,712 | — | 126,712 | — | 126,712 |
| Other comprehensive loss | — | — | — | — | (2,805) | (2,805) | — | (2,805) |
| Amortization of stock-based compensation | — | — | 11,902 | — | — | 11,902 | — | 11,902 |
| Common stock issuance, net | 6,320,862 | 63 | 85,948 | — | — | 86,011 | — | 86,011 |
| Common dividends ($1.20 per share) | — | — | — | (283,066) | — | (283,066) | — | (283,066) |
| Balance, December 31, 2024 | 237,586,882 | 2,376 | 4,592,605 | (1,874,633) | 20,940 | 2,741,288 | — | 2,741,288 |
| Net income (loss) | — | — | — | 155,609 | — | 155,609 | (99) | 155,510 |
| Other comprehensive loss | — | — | — | — | (24,511) | (24,511) | — | (24,511) |
| Contribution from noncontrolling interests | — | — | — | — | — | — | 2,046 | 2,046 |
| Amortization of stock-based compensation | — | — | 16,215 | — | — | 16,215 | — | 16,215 |
| Common stock issuance, net | 14,110,574 | 141 | 227,450 | — | — | 227,591 | — | 227,591 |
| Common dividends ($1.20 per share) | — | — | — | (294,351) | — | (294,351) | — | (294,351) |
| Balance, December 31, 2025 | 251,697,456 | $2,517 | $4,836,270 | $(2,013,375) | $(3,571) | $2,821,841 | $1,947 | $2,823,788 |
The text of this filing, as the company filed it with the SEC, without its images or exhibits. This is not investment advice.